Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 2.31% |
| 2 | Technology | 1.26% |
| 3 | Financials | 1.12% |
| 4 | Healthcare | 1.04% |
| 5 | Consumer Discretionary | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AKRX
1951
CALL
DELISTED
Akorn Inc
AKRX
| $6.37M | ﹤0.01% |
233,500
-151,700
| -39% | -$4.49M |
|
1952
CALL
Bank of Montreal
BMO
$121B
| $6.36M | ﹤0.01% |
97,000
-35,800
| -27% | -$2.33M |
|
1953
CALL
Genworth Financial
GNW
$3.74B
| $6.36M | ﹤0.01% |
1,281,300
+999,900
| +355% | +$3.84M |
|
|
LNW
1954
DELISTED
Light & Wonder
LNW
| $6.35M | ﹤0.01% |
563,813
+230,132
| +69% | +$2.26M |
|
|
QVCGA
1955
PUT
DELISTED
QVC Group Inc Series A
QVCGA
| $6.35M | ﹤0.01% |
6,538
+5,807
| +794% | +$6.4M |
|
1956
Qorvo
QRVO
$8.39B
| $6.34M | ﹤0.01% |
+113,821
| New | +$6.46M |
|
1957
Hershey
HSY
$37.2B
| $6.34M | ﹤0.01% |
66,301
+790
| +1% | +$83.6K |
|
1958
CALL
State Street SPDR S&P Bank ETF
KBE
$1.7B
| $6.34M | ﹤0.01% |
189,800
-45,900
| -19% | -$1.49M |
|
|
TBRA
1959
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
| $6.33M | ﹤0.01% |
+159,374
| New | +$1.78M |
|
1960
CALL
Pacira BioSciences
PCRX
$1.03B
| $6.33M | ﹤0.01% |
184,900
+126,900
| +219% | +$4.97M |
|
|
OA
1961
CALL
DELISTED
Orbital ATK, Inc.
OA
| $6.33M | ﹤0.01% |
83,000
-45,300
| -35% | -$3.61M |
|
|
BEAV
1962
PUT
DELISTED
B/E Aerospace Inc
BEAV
| $6.3M | ﹤0.01% |
121,900
-2,400
| -2% | -$116K |
|
|
CVT
1963
PUT
DELISTED
CVENT, INC.
CVT
| $6.29M | ﹤0.01% |
198,400
+138,100
| +229% | +$4.51M |
|
1964
State Street SPDR S&P Metals & Mining ETF
XME
$4.81B
| $6.29M | ﹤0.01% |
237,140
-879,448
| -79% | -$23.6M |
|
1965
Berkshire Hathaway Class A
BRK.A
$1.08T
| $6.27M | ﹤0.01% |
29
+27
| +1,350% | +$5.92M |
|
1966
NXP Semiconductors
NXPI
$56.3B
| $6.27M | ﹤0.01% |
61,463
-25,406
| -29% | -$2.15M |
|
1967
PUT
Ovintiv
OVV
$17.8B
| $6.27M | ﹤0.01% |
91,080
-5,040
| -5% | -$226K |
|
1968
PUT
FMC
FMC
$1.39B
| $6.26M | ﹤0.01% |
149,429
-64,683
| -30% | -$2.66M |
|
1969
PUT
Invesco CurrencyShares Canadian Dollar Trust
FXC
$66.9M
| $6.26M | ﹤0.01% |
83,000
+22,200
| +37% | +$1.68M |
|
|
BBBY
1970
DELISTED
Bed Bath & Beyond Inc
BBBY
| $6.26M | ﹤0.01% |
145,115
+22,007
| +18% | +$978K |
|
1971
CALL
Direxion Daily S&P 500 Bull 3x ETF
SPXL
$6.88B
| $6.25M | ﹤0.01% |
257,200
-726,800
| -74% | -$17.5M |
|
1972
PUT
Jack in the Box
JACK
$316M
| $6.25M | ﹤0.01% |
65,100
-70,700
| -52% | -$6.7M |
|
|
BRSL
1973
PUT
Brightstar Lottery PLC
BRSL
$2.1B
| $6.24M | ﹤0.01% |
256,100
-15,700
| -6% | -$346K |
|
1974
CALL
Itaú Unibanco
ITUB
$83.9B
| $6.24M | ﹤0.01% |
1,293,577
+314,976
| +32% | +$1.49M |
|
1975
PUT
Arista Networks
ANET
$255B
| $6.24M | ﹤0.01% |
1,172,800
-4,761,600
| -80% | -$22.7M |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass deployed $7.99B of net new capital in Q3 2016, opening 1,347 new positions and adding to 3,278 existing holdings. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
By sector, the portfolio is most concentrated in Consumer Staples at 2.3% of assets, up from 0.28% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Apple, an estimated $762M trimmed.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.